Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s displayed revision/version has been updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:40:55.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The site revision label has been updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T19:27:25.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:11:43.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and the older Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T09:23:33.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page, warning that information may not be up to date and that the NIH Clinical Center is open, and the site revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:36:28.000Z thumbnail image

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.